GW1929

Bioss Antibodies

GW1929 [196808-24-9]

16

Research Use Only

>98%

Potent and subtype-selective (>1000-fold) PPARgamma agonist [1]. Angiogenesis inhibitor [3]. Apoptosis inhibitor [4]. Anti-inflammatory [4]. Anti-hyperglycemic and anti-hyperlipidemic agent [1]. Antidiabetic. The glucose-lowering effect in rats is 100-fold more potent than that of troglitazone [2].

-20°C

51202000